litlas
ログインアカウント作成

Bart Barlogie

1976–2024 年に発表

別表記
BART BARLOGIE
254
論文数
67,135
被引用数
139
h 指数
250
i10 指数

被引用数

Bart Barlogie の年別被引用数1948 年: 被引用 14 件1968 年: 被引用 1 件1977 年: 被引用 2 件1978 年: 被引用 1 件1979 年: 被引用 2 件1980 年: 被引用 5 件1981 年: 被引用 2 件1982 年: 被引用 8 件1983 年: 被引用 5 件1984 年: 被引用 3 件1985 年: 被引用 9 件1986 年: 被引用 11 件1987 年: 被引用 9 件1988 年: 被引用 17 件1989 年: 被引用 28 件1990 年: 被引用 11 件1991 年: 被引用 17 件1992 年: 被引用 23 件1993 年: 被引用 23 件1994 年: 被引用 41 件1995 年: 被引用 40 件1996 年: 被引用 51 件1997 年: 被引用 69 件1998 年: 被引用 89 件1999 年: 被引用 105 件2000 年: 被引用 195 件2001 年: 被引用 229 件2002 年: 被引用 323 件2003 年: 被引用 456 件2004 年: 被引用 489 件2005 年: 被引用 503 件2006 年: 被引用 575 件2007 年: 被引用 724 件2008 年: 被引用 687 件2009 年: 被引用 829 件2010 年: 被引用 674 件2011 年: 被引用 843 件2012 年: 被引用 635 件2013 年: 被引用 580 件2014 年: 被引用 555 件2015 年: 被引用 484 件2016 年: 被引用 469 件2017 年: 被引用 461 件2018 年: 被引用 394 件2019 年: 被引用 1,407 件2020 年: 被引用 1,337 件2021 年: 被引用 1,349 件2022 年: 被引用 923 件2023 年: 被引用 501 件2024 年: 被引用 896 件2025 年: 被引用 340 件2026 年: 被引用 8 件1949〜1967 年は被引用が無いため表示していません1969〜1976 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,830 件、この内訳の 29.9%イタリア: 引用元論文 1,035 件、この内訳の 6.4%中国: 引用元論文 975 件、この内訳の 6%ドイツ: 引用元論文 965 件、この内訳の 6%イギリス: 引用元論文 938 件、この内訳の 5.8%フランス: 引用元論文 869 件、この内訳の 5.4%スペイン: 引用元論文 679 件、この内訳の 4.2%カナダ: 引用元論文 535 件、この内訳の 3.3%オランダ: 引用元論文 498 件、この内訳の 3.1%ギリシャ: 引用元論文 390 件、この内訳の 2.4%日本: 引用元論文 384 件、この内訳の 2.4%オーストラリア: 引用元論文 354 件、この内訳の 2.2%
0%29.9%その他 22.9%

機関

分野

  • Medicine67.5%
  • Biochemistry, Genetics and Molecular Biology23.9%
  • Immunology and Microbiology4.9%
  • Computer Science1.3%
  • Mathematics0.3%
  • Chemistry0.3%
  • その他1.8%

トピック

  • Multiple Myeloma Research and Treatments16.3%
  • Protein Degradation and Inhibitors6.1%
  • Peptidase Inhibition and Analysis3.4%
  • Ubiquitin and proteasome pathways3%
  • Cancer Treatment and Pharmacology2.5%
  • Chronic Lymphocytic Leukemia Research2%
  • その他66.7%

共著者

全論文

検索で開く
  1. International Staging System for Multiple Myeloma

    著者: Philip R. Greipp, Jesús F. San Miguel, Brian G.M. Durie, John J. Crowley, Bart Barlogie, Joan Bladé, Mario Boccadoro, J. A. Child, Hervé Avet‐Loiseau, Robert A. Kyle, Juan José Lahuerta, Heinz Ludwig, Gareth J. Morgan, Raymond Powles, Kazuyuki Shimizu, Chaim Shustik, Pieter Sonneveld, Patrizia Tosi, Ingemar Turesson, Jan Westin - Journal of Clinical Oncology 2005 被引用: 2,918

  2. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

    著者: Brian G.M. Durie, Antje Hoering, Muneer H. Abidi, S. Vincent Rajkumar, Joshua Epstein, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J. Reu, Christopher M. Reynolds, Rachael Sexton, Robert Z. Orlowski, Bart Barlogie, Angela Dispenzieri - The Lancet 2016 被引用: 888

  3. International uniform response criteria for multiple myeloma

    著者: Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel, J Bladé, Bart Barlogie, Kenneth C. Anderson, Morie A. Gertz, Meletios Α. Dimopoulos, Jan Westin, Pieter Sonneveld, Heinz Ludwig, Gösta Gahrton, Meral Beksaç, John Crowley, Andrew Belch, M Boccadaro, Ingemar Turesson, D. Joshua, David H. Vesole, Robert A. Kyle, Raymond Alexanian, Guido Tricot, Michel Attal, Giampaolo Merlini, R Powles, Paul G. Richardson, Kazuyuki Shimizu, Patrizia Tosi, Gareth J. Morgan, S. Vincent Rajkumar, on behalf of the International Myeloma Working Group - Leukemia 2006 被引用: 2,639

  4. The molecular classification of multiple myeloma

    著者: Fenghuang Zhan, Yongsheng Huang, Simona Colla, Peter Stewart, Ichiro Hanamura, Sushil Gupta, Joshua Epstein, Shmuel Yaccoby, Jeffrey R. Sawyer, Bart Burington, Elias Anaissie, Klaus Hollmig, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Ronald C. Walker, Maurizio Zangari, John Crowley, Bart Barlogie, John D. Shaughnessy - Blood 2006 被引用: 1,142

  5. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    著者: Robert A. Kyle, Brian G.M. Durie, S. Vincent Rajkumar, Ola Landgren, Joan Bladé, Giampaolo Merlini, Nicolaus Kröger, Hermann Einsele, David H. Vesole, Meletios Α. Dimopoulos, Jesús F. San Miguel, Hervé Avet‐Loiseau, Roman Hájek, W M Chen, Kenneth C. Anderson, Heinz Ludwig, Pieter Sonneveld, S Pavlovsky, Antonio Palumbo, Paul G. Richardson, Bart Barlogie, Patricia T. Greipp, Robert Vescio, Ingemar Turesson, Jan Westin, Mario Boccadoro, on behalf of the International Myeloma Working Group - Leukemia 2010 被引用: 876

  6. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

    著者: Leo Rasche, Shweta S. Chavan, Owen Stephens, Pragi Patel, Ruslana G. Tytarenko, Cody Ashby, Michael Bauer, Joshua Epstein, S Deshpande, Christopher P. Wardell, Tímea Buzder, Gábor Molnár, Maurizio Zangari, Frits van Rhee, Sharmilan Thanendrarajan, Carolina Schinke, Joshua Epstein, Faith E. Davies, Brian A. Walker, Tobias Meißner, Bart Barlogie, Gareth J. Morgan, Niels Weinhold - Nature Communications 2017 被引用: 419

  7. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

    著者: Seema Singhal, Jayesh Mehta, Raman Desikan, Dan Ayers, Paula K. Roberson, Paul Eddlemon, Nikhil C. Munshi, Elias Anaissie, Carla S. Wilson, Madhav V. Dhodapkar, Jerome B. Zeldis, David S. Siegel, John Crowley, Bart Barlogie - New England Journal of Medicine 1999 被引用: 2,590

  8. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    著者: Brett T. Thorn, Zhichao Liu, Stephen Harris, Baitang Ning, Lei Xu, Lun Yang, Huixiao Hong, Jie Liu, Zhiguang Li, James C. Fuscoe, Leming Shi, Qiang Shi, Weigong Ge, Min Zhang, Minjun Chen, Roger Perkins, Zhining Wen, Weida Tong, Reena Philip, Uwe Scherf, Francisco Martínez-Murillo, Rong Tang, Gene Pennello, Brandon D. Gallas, Gregory Campbell, Lakshmi Vishnuvajjala, F. W. Samuelson, Živana Težak, Weijie Chen, Wendell Jones, Joel S. Parker, Fabien Campagne, Stephen J. Walker, Zhenqiang Su, Joshua Xu, Hong Fang, Feng Qian, Dhivya Arasappan, Zhenqiang Su, Russell D. Wolfinger, Padraic Neville, Tzu‐Ming Chu, Li Li, Wenjun Bao, Kelci Miclaus, Pei-Yi Tan, Wendy Czika, Federico Goodsaid, Mat Soukup, Li Zhang, Jialü Zhang, Sue Jane Wang, Lajos Pusztai, John D. Shaughnessy, Bart Barlogie, Yiming Zhou, Matthias Fischer, André Oberthuer, Yvonne Kahlert, Frank Berthold, Russell S. Thomas, J.-H Chou, Richard S. Paules, Jennifer Fostel, Pierre R. Bushel, Mark R. Fielden, Pan Du, Simon Lin, Cesare Furlanello, Giuseppe Jurman, Samantha Riccadonna, Roberto Visintainer, Xijin Ge, Dalila B. Megherbi, Manuel Madera, W. Fraser Symmans, May D. Wang, R. Mitchell Parry, Todd H. Stokes, John H. Phan, Andrea B. Moffitt, Jun Luo, John H. Zhang, Matthew Woods, Eric W. Wang, Hans Bitter, Dilafruz Juraeva, Benedikt Brors, Frank Westermann, Roland Eils, Johan Trygg, Max Bylesjö, Jie Cheng, Jing Cheng, Timothy S. Davison, Mauro Delorenzi, Vlad Popovici, Youping Deng, Viswanath Devanarayan, Richard Judson ほか 101 名 - Nature Biotechnology 2010 被引用: 915

  9. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

    著者: Michèle Cavo, Evangelos Terpos, Cristina Nanni, Philippe Moreau, Suzanne Lentzsch, Sonja Zweegman, Jens Hillengaß, Monika Engelhardt, Saad Z. Usmani, David H. Vesole, Jesús F. San Miguel, Shaji Kumar, Paul G. Richardson, Joseph Mıkhael, Fernando Leal da Costa, Meletios Α. Dimopoulos, Chiara Zingaretti, Niels Abildgaard, Hartmut Goldschmidt, Robert Z. Orlowski, Wee Joo Chng, Hermann Einsele, Sagar Lonial, Bart Barlogie, Kenneth C. Anderson, S. Vincent Rajkumar, Brian G.M. Durie, Elena Zamagni - The Lancet Oncology 2017 被引用: 520

  10. CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

    著者: Eric D. Hsi, Roxanne Steinle, Balaji Balasa, Susann Szmania, Aparna Draksharapu, Benny P. Shum, Mahrukh Huseni, David B. Powers, Amulya Nanisetti, Yin Zhang, Audie Rice, Anne van Abbema, Melanie Wong, Gao Liu, Fenghuang Zhan, Myles Dillon, Shihao Chen, Susan Rhodes, Franklin Fuh, Naoya Tsurushita, Shankar Kumar, Vladimir Vexler, John D. Shaughnessy, Bart Barlogie, Frits van Rhee, Mohamad A. Hussein, Daniel Afar, Marna Williams - Clinical Cancer Research 2008 被引用: 560

  11. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

    著者: Saad Z. Usmani, Christoph Heuck, Alyson E. Mitchell, Jackie Szymonifka, Bijay Nair, Antje Hoering, Yazan Alsayed, Sarah Waheed, Sajjad Haider, Alejandro Restrepo, Frits van Rhee, John Crowley, Bart Barlogie - Haematologica 2012 被引用: 389

  12. A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

    著者: Paul G. Richardson, Bart Barlogie, James R. Berenson, Seema Singhal, Sundar Jagannath, David Irwin, S. Vincent Rajkumar, Gordan Srkalović, Melissa Alsina, Raymond Alexanian, David S. Siegel, Robert Z. Orlowski, David J. Kuter, Steven Limentani, Stephanie J. Lee, Teru Hideshima, Dixie‐Lee Esseltine, Michael Kauffman, Julian Adams, David P. Schenkein, Kenneth C. Anderson - New England Journal of Medicine 2003 被引用: 2,641

  13. Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma

    著者: Leo Rasche, Edgardo Angtuaco, James E. McDonald, Amy Buros, Caleb Stein, Charlotte Pawlyn, Sharmilan Thanendrarajan, Carolina Schinke, Rohan Samant, Shmuel Yaccoby, Brian A. Walker, Joshua Epstein, Maurizio Zangari, Frits van Rhee, Tobias Meißner, Hartmut Goldschmidt, Kari Hemminki, Richard S. Houlston, Bart Barlogie, Faith E. Davies, Gareth J. Morgan, Niels Weinhold - Blood 2017 被引用: 248

  14. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma

    著者: Eileen M. Boyle, Shayu Deshpande, Ruslana G. Tytarenko, Cody Ashby, Yan Wang, Michael Bauer, Sarah K. Johnson, Christopher P. Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Façon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H Rustad, Francesco Maura, Ola Landgren, Fenghuang Zhan, Frits van Rhee, Carolina Schinke, Faith E. Davies, Gareth J. Morgan, Brian A. Walker - Nature Communications 2021 被引用: 138

  15. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    著者: John D. Shaughnessy, Fenghuang Zhan, Bart Burington, Yongsheng Huang, Simona Colla, Ichiro Hanamura, Peter Stewart, Bob Kordsmeier, Christopher E. Randolph, David R. Williams, Yan Xiao, Hongwei Xu, Joshua Epstein, Elias Anaissie, Somashekar G. Krishna, Michele Cottler‐Fox, Klaus Hollmig, Abid Mohiuddin, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Jeffrey R. Sawyer, Yazan Alsayed, Ronald C. Walker, Maurizio Zangari, John Crowley, Bart Barlogie - Blood 2006 被引用: 916

  16. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation

    著者: Ichiro Hanamura, Peter Stewart, Yongsheng Huang, Fenghuang Zhan, Madhumita Santra, Jeffrey R. Sawyer, Klaus Hollmig, Maurizio Zangarri, Mauricio Pineda‐Roman, Frits van Rhee, Federica Cavallo, Bart Burington, John Crowley, Guido Tricot, Bart Barlogie, John D. Shaughnessy - Blood 2006 被引用: 479

  17. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level

    著者: Lukas John, Alexandra M. Poos, Alexander Brobeil, Carolina Schinke, Stefanie Huhn, Nina Prokoph, Raphael Lutz, Barbara Wagner, Maurizio Zangari, Stephan M. Tirier, Jan‐Philipp Mallm, Sabrina Schumacher, Dominik Vonficht, Llorenç Solé‐Boldo, Sabine Quick, Simon Steiger, Moritz J. Przybilla, Katharina Bauer, Anja Baumann, Stefan Hemmer, Christoph Rehnitz, Christian Lückerath, Christos Sachpekidis, Gunhild Mechtersheimer, Uwe Haberkorn, Antonia Dimitrakopoulou‐Strauss, Philipp Reichert, Bart Barlogie, Carsten Müller‐Tidow, Hartmut Goldschmidt, Jens Hillengaß, Leo Rasche, Simon Haas, Frits van Rhee, Karsten Rippe, Marc S. Raab, Sandra Sauer, Niels Weinhold - Nature Communications 2023 被引用: 38

  18. The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states

    著者: Leo Rasche, Carolina Schinke, Francesco Maura, Michael Bauer, Cody Ashby, Shayu Deshpande, Alexandra M. Poos, Maurizio Zangari, Sharmilan Thanendrarajan, Faith E. Davies, Brian A. Walker, Bart Barlogie, Ola Landgren, Gareth J. Morgan, Frits van Rhee, Niels Weinhold - Nature Communications 2022 被引用: 76

  19. The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

    著者: Erming Tian, Fenghuang Zhan, Ronald C. Walker, Erik Rasmussen, Yupo Ma, Bart Barlogie, John D. Shaughnessy - New England Journal of Medicine 2003 被引用: 1,505

  20. Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

    著者: Christina M. Annunziata, R. Eric Davis, Yulia N. Demchenko, William Bellamy, Ana Gabrea, Fenghuang Zhan, Georg Lenz, Ichiro Hanamura, George W. Wright, Wenming Xiao, Sandeep S. Davé, Elaine M. Hurt, Bruce K. Tan, Hong Zhao, Owen Stephens, Madhumita Santra, David R. Williams, Lenny Dang, Bart Barlogie, John D. Shaughnessy, W. Michael Kuehl, Louis M. Staudt - Cancer Cell 2007 被引用: 949

  21. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

    著者: Twyla B. Bartel, Jeff Haessler, Tracy L. Brown, John D. Shaughnessy, Frits van Rhee, Elias Anaissie, Terri L. Alpe, Edgardo Angtuaco, Ronald C. Walker, Joshua Epstein, John Crowley, Bart Barlogie - Blood 2009 被引用: 523

  22. Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)

    著者: Brian G.M. Durie, Antje Hoering, Rachael Sexton, Muneer H. Abidi, Joshua Epstein, S. Vincent Rajkumar, Angela Dispenzieri, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J. Reu, Christopher M. Reynolds, Robert Z. Orlowski, Bart Barlogie - Blood Cancer Journal 2020 被引用: 252

  23. Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients

    著者: Susann Szmania, Natalia Lapteva, Tarun K. Garg, Amy D Greenway, Joshuah D Lingo, Bijay Nair, Katie L. Stone, Emily Woods, Junaid Khan, Justin Stivers, Susan Panozzo, Dario Campana, William Bellamy, Molly Robbins, Joshua Epstein, Shmuel Yaccoby, Sarah Waheed, Adrian P. Gee, Michele Cottler‐Fox, Cliona M. Rooney, Bart Barlogie, Frits van Rhee - Journal of Immunotherapy 2014 被引用: 180

  24. Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

    著者: Leo Rasche, Daisy Alapat, Manoj Kumar, Grant Gershner, James E. McDonald, Christopher P. Wardell, Rohini Samant, Rudy Van Hemert, Joshua Epstein, Anjana Williams, Sharmilan Thanendrarajan, Carolina Schinke, Michael Bauer, Cody Ashby, Ruslana G. Tytarenko, Frits van Rhee, Brian A. Walker, Maurizio Zangari, Bart Barlogie, Faith E. Davies, Gareth J. Morgan, Niels Weinhold - Leukemia 2018 被引用: 152